People · Operator
Named in public records as an officer, director or promoter · active 2015–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ZWI Therapeutics, Inc. | — | Biotechnology | Series A | $10.0M | $256.9M | 2021 |
| Gemstone BioTherapeutics, LLC | — | Biotechnology | Seed | $2.3M | $31.1M | 2015 |
Xin Huang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Xin Huang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| David Oros | 1 | 5 |
| Geoff MacKay | 1 | 5 |
| George Davis | 1 | 4 |
| SHAOYI JIANG | 1 | 2 |
| Sharon Gerecht | 1 | 1 |
| ANDREW KEEFE | 1 | 1 |
| CHENG XING | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.